Atlanta, GA (PRWEB) January 25, 2012 MissionIR would like to highlight FluoroPharma Medical, Inc. (OTCBB: FPMI). FluoroPharma Medical is a biopharmaceutical company focused on discovering and developing patented Positron Emission Tomography (PET) imaging products to improve patient management by evaluating cardiac disease at the cellular and molecular levels. The company is currently advancing two products in clinical trials to fulfill critical unmet medical needs.
Today, Seeking Alpha
Tidak ada komentar:
Posting Komentar